NGM Biopharmaceuticals Stock Price

-1.24 (-6.69%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NGM Biopharmaceuticals Inc NGM NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-1.24 -6.69% 17.2726 17.21 18.80 18.72 18.51 14:23:36
Bid Price Ask Price Spread Spread % News
17.20 17.32 0.12 0.69% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,223 101,996 $ 17.86 $ 1,821,487 217,119 8.55 - 28.32
Last Trade Time Type Quantity Stock Price Currency
14:23:47 2 $ 17.20 USD

NGM Biopharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.20B 68.14M 23.63M $ 103.54M $ -61.81M -0.68 -19.43
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -51.56k 1.50%

more financials information »

NGM Biopharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NGM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.2219.5317.2118.87125,232-1.95-10.13%
1 Month18.9819.8017.2118.61138,639-1.71-9.0%
3 Months20.4923.9517.2120.47250,609-3.22-15.7%
6 Months16.1828.329.24517.62336,3601.096.75%
1 Year13.8928.328.5517.08266,3923.3824.35%
3 Years15.1928.328.5516.79223,6982.0813.71%
5 Years15.1928.328.5516.79223,6982.0813.71%

NGM Biopharmaceuticals Description

NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's products include NGM282 (aldafermin), NGM313 (MK-3655), NGM120, NGM120, NGM621, and NGM395, all these are focused on NASH, diabetes, oncology, AMD and metabolic disease.

Your Recent History
NGM Biopha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.